There's only one analyst who follows BGSF. On April 28, the analyst's report showed an FY 17 estimate of $1.27 (including with his projections). He must have significantly increased his revenue growth numbers and updated for debt paydown, margin improvement and shares outstanding. He was previously showing only 6% growth from FY17/FY16, which was too low by at least 4-5%. I think that if the company can keep up the growth and meets their numbers throughout the 3rd quarter's results, we should see $20/share.